Novellus is a biotechnology company working to develop engineered cellular medicines.
Business Model:
Revenue: $0
Employees: 11-50
Novellus Therapeutics was acquired by
Brooklyn ImmunoTherapeutics.
The acquisition happend on 2021-06-14.
Details of the transaction were not public
Address: 1035 Cambridge Street,
City: Cambridge
State: MA
Zip: 02141
Country: US
Novellus is a biotechnology company working to develop engineered cellular medicines. The company uses its non-immunogenic mRNA molecules to reprogram and gene-edit cells safely, and with high efficiency. They engineer precision medicines for patient segments and select from its technology toolbox for in vivo, ex vivo, allogeneic and autologous delivery. Novellus platform enables the high-level expression of gene-editing and cell-reprogramming proteins for high-specificity gene repair and both autologous and allogeneic cell therapies. The company is advancing its lead program, a breakthrough therapy for a rare dermatologic disease, through pre-clinical studies. Novellus was founded in 2015 and is headquartered in Cambridge, Massachusetts, United States.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2018 | Debt Financing | $1M | 9/2020 | Series C | 6 | $57M |
Cormorant Asset Management HBM Healthcare Investments AG Novartis Venture Fund OrbiMed Pontifax Wellington Management Cormorant Asset Management HBM Healthcare Investments AG Novartis Venture Fund OrbiMed Pontifax Wellington Management |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|